PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
The high cost of specialty drugs to treat inflammatory disorders, cancer, multiple sclerosis, and other serious illnesses continues to be a critical issue for plan…
The “Big 3” Pharmacy Benefit Managers (OptumRx, Express Scripts, CVS Caremark) released updates to their 2019 formulary exclusions and this year’s changes come with expansion…
Nobody is immune from the effects of opioid misuse. A tragic number succumb to fatal overdoses—one every 13 minutes. Addiction also leaves its mark on…
On October 26, 2017, the President declared the opioid crisis a national public health emergency under federal law. Six short months later, the bipartisan Senate…
Recently it was announced that Regeneron and Sanofi had entered into an agreement with Express Scripts to drastically reduce the price tag on Praulent, a…
Issue: March 2018 – FRMC PSG’s Pharmacy Benefit Management Institute (PBMI) is an independent research and education organization that focuses on the complexities in the …
Understanding Why Cost Concerns Continue For the last 7 years, PSG’s Pharmacy Benefit Management Institute (PBMI) has produced original research focused on specialty drug benefit…
If you’re a health system, you can no longer afford to silo drug management. Effective Pharmacy Benefit Management (PBM) engagement involves integrating the pharmacy resources…
Widespread Influenza activity is occurring across the United States and the CDC is reporting that thirty nine (39) states plus Puerto Rico are currently experiencing…
